WDNA vs. BBP
Compare and contrast key facts about WisdomTree BioRevolution Fund (WDNA) and Virtus LifeSci Biotech Products ETF (BBP).
WDNA and BBP are both exchange-traded funds (ETFs), meaning they are traded on stock exchanges and can be bought and sold throughout the day. WDNA is a passively managed fund by WisdomTree that tracks the performance of the WisdomTree BioRevolution Index. It was launched on Jun 3, 2021. BBP is a passively managed fund by Virtus Investment Partners that tracks the performance of the LifeSci Biotechnology Products Index. It was launched on Dec 17, 2014. Both WDNA and BBP are passive ETFs, meaning that they are not actively managed but aim to replicate the performance of the underlying index as closely as possible.
Scroll down to visually compare performance, riskiness, drawdowns, and other indicators and decide which better suits your portfolio: WDNA or BBP.
Correlation
The correlation between WDNA and BBP is 0.86, which is considered to be high. That indicates a strong positive relationship between their price movements. Having highly-correlated positions in a portfolio may signal a lack of diversification, potentially leading to increased risk during market downturns.
Performance
WDNA vs. BBP - Performance Comparison
Key characteristics
WDNA:
-0.48
BBP:
0.43
WDNA:
-0.53
BBP:
0.74
WDNA:
0.94
BBP:
1.09
WDNA:
-0.22
BBP:
0.48
WDNA:
-1.11
BBP:
1.23
WDNA:
9.43%
BBP:
7.72%
WDNA:
22.02%
BBP:
22.11%
WDNA:
-51.90%
BBP:
-44.32%
WDNA:
-47.12%
BBP:
-11.57%
Returns By Period
In the year-to-date period, WDNA achieves a -13.52% return, which is significantly lower than BBP's 3.73% return.
WDNA
-13.52%
-3.72%
-8.38%
-13.63%
N/A
N/A
BBP
3.73%
-2.61%
3.04%
8.07%
6.43%
9.30%
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
WDNA vs. BBP - Expense Ratio Comparison
WDNA has a 0.45% expense ratio, which is lower than BBP's 0.79% expense ratio.
Risk-Adjusted Performance
WDNA vs. BBP - Risk-Adjusted Performance Comparison
This table presents a comparison of risk-adjusted performance metrics for WisdomTree BioRevolution Fund (WDNA) and Virtus LifeSci Biotech Products ETF (BBP). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
Dividends
WDNA vs. BBP - Dividend Comparison
Neither WDNA nor BBP has paid dividends to shareholders.
| TTM | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | |
|---|---|---|---|---|---|---|---|---|---|---|
WDNA WisdomTree BioRevolution Fund | 0.00% | 0.80% | 0.37% | 0.11% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
BBP Virtus LifeSci Biotech Products ETF | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.18% | 0.00% | 1.29% |
Drawdowns
WDNA vs. BBP - Drawdown Comparison
The maximum WDNA drawdown since its inception was -51.90%, which is greater than BBP's maximum drawdown of -44.32%. Use the drawdown chart below to compare losses from any high point for WDNA and BBP. For additional features, visit the drawdowns tool.
Volatility
WDNA vs. BBP - Volatility Comparison
WisdomTree BioRevolution Fund (WDNA) and Virtus LifeSci Biotech Products ETF (BBP) have volatilities of 7.42% and 7.12%, respectively, indicating that both stocks experience similar levels of price fluctuations. This suggests that the risk associated with both stocks, as measured by volatility, is nearly the same. The chart below showcases a comparison of their rolling one-month volatility.